Skip to main content

Empagliflozin 5 mg / Metformin 1000 mg 

Empagliflozin 12.5 mg / Metformin 1000 mg 

Empaxa-Met 12.5/1000 mg and 5/1000 mg
Product Description
  • A fixed dose combination of a sodium-glucose co-transporter 2 (SGLT2) inhibitor and metformin indicated for the treatment of type 2 diabetes mellitus (T2D).Highly effective treatment for T2D at any disease stage.
  • Has additive effect in reducing HbA1c, post-prandial and fasting blood glucose levels.
  • Has cardioprotective and renoprotective benefits.
  • Low risk of hypoglycemia.
  • Exerts a favorable effect on nonglycemic outcomes, including blood pressure.
  • Promotes weight loss.